Literature DB >> 1317385

Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.

T D Geracioti1, D N Orth, N N Ekhator, B Blumenkopf, P T Loosen.   

Abstract

CRH, a hypothalamic peptide that is the most potent ACTH secretagogue known, also appears to be produced in the cerebral cortex and spinal cord. Depressed patients have blunted responses to exogenous CRH and normal to high concentrations of CRH immunoreactivity in single morning samples of lumbar cerebrospinal fluid (CSF). Although these data suggest that depression may be associated with hypersecretion of CRH, it has also been postulated that central nervous system insufficiency of CRH might have a pathophysiological role in certain depressive syndromes. We continuously sampled lumbar CSF via indwelling subarachnoid catheters from 1100-1700 h and measured CRH at 10-min intervals in depressed patients and normal subjects. A standardized mixed liquid meal was administered at 1300 h. CSF CRH was strikingly reduced in depressed patients compared to normal subjects [4.2 +/- 1.1 pmol/L vs. 13 +/- 2.1 pmol/L (mean +/- SEM), respectively, P less than 0.01 by Wilcoxon test]. CSF CRH concentrations rose progressively during the experiment in both groups, suggesting a diurnal rhythm and, possibly, response to a test meal. CRH had a very brief half-life in CSF (less than 10 min), suggesting that the spinal cord is the origin of CRH in lumbar CSF. The rapid transients in CSF CRH concentration demonstrate that single samples provide very limited information. There were no intraindividual correlations between CSF CRH concentrations and those of either plasma ACTH or cortisol, both of which rose in response to eating. The present data show that impaired central nervous system secretion of CRH can exist during states of severe depression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317385     DOI: 10.1210/jcem.74.6.1317385

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder.

Authors:  J D Bremner; J Licinio; A Darnell; J H Krystal; M J Owens; S M Southwick; C B Nemeroff; D S Charney
Journal:  Am J Psychiatry       Date:  1997-05       Impact factor: 18.112

Review 2.  Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.

Authors:  Victoria B Risbrough; Murray B Stein
Journal:  Horm Behav       Date:  2006-07-25       Impact factor: 3.587

3.  Serial CSF sampling over a period of 30 h via an indwelling spinal catheter in healthy volunteers: headache, back pain, tolerability and measured acetylcholine profile.

Authors:  Izaak den Daas; Johan Wemer; Khalid Abou Farha; Wim Tamminga; Theo de Boer; Rob Spanjersberg; Michel M R F Struys; Anthony R Absalom
Journal:  Eur J Clin Pharmacol       Date:  2012-11-10       Impact factor: 2.953

4.  Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus.

Authors:  M A Poca; M Mataró; J Sahuquillo; R Catalán; J Ibañez; R Galard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

5.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Authors:  David De Wied; Hein O. Sigling
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

6.  Biomarkers in chronic adult hydrocephalus.

Authors:  Andrew Tarnaris; Laurence D Watkins; Neil D Kitchen
Journal:  Cerebrospinal Fluid Res       Date:  2006-10-04

7.  The changes in, and relationship between, plasma nitric oxide and corticotropin-releasing hormone in patients with major depressive disorder.

Authors:  Yun-Rong Lu; Yan Zhang; Ying-Bo Rao; Xi Chen; Han-Fen Lou; Yu Zhang; Hai-Yan Xie; Ping Fang; Li-Wei Hu
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-10-25       Impact factor: 2.557

8.  Increased Vascular Endothelial Growth Factor in the Ventricular Cerebrospinal Fluid as a Predictive Marker for Subsequent Ventriculoperitoneal Shunt Infection : A Comparison Study among Hydrocephalic Patients.

Authors:  Jeong-Hyun Lee; Dong-Bin Back; Dong-Hyuk Park; Yoo-Hyun Cha; Shin-Hyuk Kang; Jung-Keun Suh
Journal:  J Korean Neurosurg Soc       Date:  2012-06-30

9.  Comparison of cerebrospinal fluid biomarkers between idiopathic normal pressure hydrocephalus and subarachnoid hemorrhage-induced chronic hydrocephalus: a pilot study.

Authors:  Jeong-Hyun Lee; Dong-Hyuk Park; Dong-Bin Back; Jea-Young Lee; Chang-In Lee; Kyung-Jae Park; Shin-Hyuk Kang; Tai-Hyoung Cho; Yong-Gu Chung
Journal:  Med Sci Monit       Date:  2012-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.